Cargando…
Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017
OBJECTIVES: The objective of this study was to evaluate the performance of lateral flow immunoassay (LFA) against latex agglutination (LA), India ink and culture in point-of-care diagnosis of cryptococcus meningitis (CM). We conducted cross-sectional study among HIV-positive patients with suspected...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896259/ https://www.ncbi.nlm.nih.gov/pubmed/31806044 http://dx.doi.org/10.1186/s13104-019-4829-4 |
_version_ | 1783476739464232960 |
---|---|
author | Gitonga, Lawrence Kirimi Boru, Waqo Gufu Kwena, Arthur Maritim, Marybeth Wamicwe, Joyce Ransom, James |
author_facet | Gitonga, Lawrence Kirimi Boru, Waqo Gufu Kwena, Arthur Maritim, Marybeth Wamicwe, Joyce Ransom, James |
author_sort | Gitonga, Lawrence Kirimi |
collection | PubMed |
description | OBJECTIVES: The objective of this study was to evaluate the performance of lateral flow immunoassay (LFA) against latex agglutination (LA), India ink and culture in point-of-care diagnosis of cryptococcus meningitis (CM). We conducted cross-sectional study among HIV-positive patients with suspected CM at Mbagathi Hospital, Nairobi, April–July 2017. RESULTS: Of 124 capillary blood and serum and 99 cerebrospinal fluid (CSF) samples, LFA and LA had a concurrence on serum of 94.4%, kappa (0.88), sensitivity (100%) and specificity (91%). LFA and LA on CSF, was 97.9%, kappa (0.96), sensitivity (100%) and specificity (96%). LFA and India ink was 96.9%, kappa (0.94), sensitivity (100%) and specificity (94.1%). On CSF culture, concurrence was 72.7%, kappa (0.43), sensitivity (100%) and specificity (64%) and of LFA on capillary blood, serum and CSF was 100% with kappa (1.00), sensitivity and specificity of 100%. |
format | Online Article Text |
id | pubmed-6896259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68962592019-12-11 Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 Gitonga, Lawrence Kirimi Boru, Waqo Gufu Kwena, Arthur Maritim, Marybeth Wamicwe, Joyce Ransom, James BMC Res Notes Research Note OBJECTIVES: The objective of this study was to evaluate the performance of lateral flow immunoassay (LFA) against latex agglutination (LA), India ink and culture in point-of-care diagnosis of cryptococcus meningitis (CM). We conducted cross-sectional study among HIV-positive patients with suspected CM at Mbagathi Hospital, Nairobi, April–July 2017. RESULTS: Of 124 capillary blood and serum and 99 cerebrospinal fluid (CSF) samples, LFA and LA had a concurrence on serum of 94.4%, kappa (0.88), sensitivity (100%) and specificity (91%). LFA and LA on CSF, was 97.9%, kappa (0.96), sensitivity (100%) and specificity (96%). LFA and India ink was 96.9%, kappa (0.94), sensitivity (100%) and specificity (94.1%). On CSF culture, concurrence was 72.7%, kappa (0.43), sensitivity (100%) and specificity (64%) and of LFA on capillary blood, serum and CSF was 100% with kappa (1.00), sensitivity and specificity of 100%. BioMed Central 2019-12-05 /pmc/articles/PMC6896259/ /pubmed/31806044 http://dx.doi.org/10.1186/s13104-019-4829-4 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Note Gitonga, Lawrence Kirimi Boru, Waqo Gufu Kwena, Arthur Maritim, Marybeth Wamicwe, Joyce Ransom, James Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 |
title | Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 |
title_full | Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 |
title_fullStr | Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 |
title_full_unstemmed | Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 |
title_short | Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017 |
title_sort | point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in hiv-positive patients at an urban hospital in nairobi, kenya, 2017 |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896259/ https://www.ncbi.nlm.nih.gov/pubmed/31806044 http://dx.doi.org/10.1186/s13104-019-4829-4 |
work_keys_str_mv | AT gitongalawrencekirimi pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017 AT boruwaqogufu pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017 AT kwenaarthur pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017 AT maritimmarybeth pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017 AT wamicwejoyce pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017 AT ransomjames pointofcaretestingevaluationoflateralflowimmunoassayfordiagnosisofcryptococcusmeningitisinhivpositivepatientsatanurbanhospitalinnairobikenya2017 |